| A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy (NCT00998166) | Columbia University | 2009-06-01 |
| Trial of Poor Performance Status Patients (ToPPS) (NCT00892710) | SCRI Development Innovations, LLC | 2009-06-01 |
| CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC) (NCT00991796) | Daiichi Sankyo | 2009-06-01 |
| MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer (NCT00799240) | University of Kansas | 2009-06-01 |
| Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer (NCT00906282) | SCRI Development Innovations, LLC | 2009-06-01 |
| Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02) (NCT00881712) | University of Florida | 2009-06-01 |
| Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC (NCT00697333) | Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN | 2009-05-01 |
| Phase I Combination Ixabepilone + Cisplatin (NCT00832117) | R-Pharm | 2009-05-01 |
| Assessment of Video Assisted Thoracoscopic Surgery (VATS) Versus Open Surgery for Patients Undergoing Lobectomy (NCT00912366) | Medtronic - MITG | 2009-05-01 |
| Gefitinib 500mg Versus 250mg in Patients With NSCLC With Stable Disease After a Month Treatment of Gefitinib 250mg (NCT01017679) | Sun Yat-sen University | 2009-05-01 |
| Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer (NCT01218594) | Sun Yat-sen University | 2009-05-01 |
| Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer (NCT01017133) | Abramson Cancer Center at Penn Medicine | 2009-05-01 |
| Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung Cancer (NCT00888511) | Olfred Hansen | 2009-05-01 |
| Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer (NCT00883675) | Michael Mann | 2009-05-01 |
| Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) (NCT00923312) | CureVac | 2009-05-01 |
| Navelbine And Radiotherapy in Locally Advanced Lung Cancer (NCT00887783) | Odense University Hospital | 2009-05-01 |
| AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients (NCT00890825) | AstraZeneca | 2009-04-20 |
| AIMN Multicenter Study: 18 F-FDG PET-CT With or Without Contrast Medium in the Staging and Radiation of Lung Cancer? (NCT06168916) | IRCCS San Raffaele | 2009-04-14 |
| The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC) (NCT00887315) | University of Chicago | 2009-04-01 |
| A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis (NCT00800202) | Hoffmann-La Roche | 2009-04-01 |
| A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer (NCT00887549) | Eli Lilly and Company | 2009-04-01 |
| Chemotherapy in Treating Patients With Lung Cancer (NCT01067794) | Eli Lilly and Company | 2009-04-01 |
| Stereotactic Body Radio Therapy (SBRT) for Early-stage Non Small Cell Lung Cancer (NSCLC) (NCT00870116) | Centre Leon Berard | 2009-04-01 |
| A Retrospective Study of Biomarkers in Non-Small Cell Lung Cancer (NCT01100840) | National University Hospital, Singapore | 2009-04-01 |
| A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer (NCT00867009) | Eli Lilly and Company | 2009-04-01 |
| An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy (NCT00721981) | AstraZeneca | 2009-04-01 |
| A Study of MetMAb Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarceva (Erlotinib) (NCT00854308) | Genentech, Inc. | 2009-04-01 |
| CT-Based Versus Conventional Simulation for Palliative Radiotherapy of Non-Small Cell Lung Cancer (NCT00862030) | Alberta Health services | 2009-04-01 |
| A Study of Predictive and Prognostic Markers in Patients With Non-small Cell Lung Cancer (NCT00958555) | National University Hospital, Singapore | 2009-04-01 |
| A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash. (NCT00718315) | Hoffmann-La Roche | 2009-04-01 |
| EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC) (NCT00879866) | Merck KGaA, Darmstadt, Germany | 2009-04-01 |
| Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer (NCT00871923) | M.D. Anderson Cancer Center | 2009-03-26 |
| Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00964132) | NuRx Pharmaceuticals, Inc. | 2009-03-01 |
| A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer (NCT00855894) | Genentech, Inc. | 2009-03-01 |
| Detection of Circulating Endothelial Progenitors Cells (EPCs) in Non-small Cell Lung Cancer (NSCLC) (NCT00826683) | University Hospital, Limoges | 2009-03-01 |
| A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer (NCT00369447) | YM BioSciences | 2009-03-01 |
| TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung Cancer (NCT00940069) | Hunan Province Tumor Hospital | 2009-03-01 |
| A Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC) (NCT00787852) | Brown University | 2009-03-01 |
| Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma (NCT00903292) | National Cheng-Kung University Hospital | 2009-03-01 |
| Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC (NCT00966472) | Ottawa Hospital Research Institute | 2009-03-01 |
| Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer (NCT00874588) | Fukushima Medical University | 2009-03-01 |
| Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study (NCT00686465) | Ontario Clinical Oncology Group (OCOG) | 2009-03-01 |
| A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC (NCT00743938) | Bristol-Myers Squibb | 2009-03-01 |
| Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA) for Mediastinal Re-staging of Non-small Cell Lung Cancer(NSCLC) (NCT00859742) | National Cancer Center, Korea | 2009-03-01 |
| Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen (NCT00908336) | Hospital Arnau de Vilanova | 2009-03-01 |
| A Study of Ridaforolimus in Non-Small Cell Lung Cancer (NSCLC) Patients With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutations (MK-8669-021 AM1) (NCT00818675) | Merck Sharp & Dohme LLC | 2009-03-01 |
| Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer (NCT00828022) | Soroka University Medical Center | 2009-03-01 |
| A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before (NCT00870870) | Eli Lilly and Company | 2009-03-01 |
| Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC) (NCT00862134) | Proacta, Incorporated | 2009-03-01 |
| Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer (NCT00880971) | Chinese Academy of Medical Sciences | 2009-02-18 |
| Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations (NCT00891579) | Chinese Society of Lung Cancer | 2009-02-01 |
| Sunitinib Non Small Cell Lung Cancer Patients Over 70 (NCT00864721) | US Oncology Research | 2009-02-01 |
| E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC) (NCT00832819) | Eisai Co., Ltd. | 2009-02-01 |
| Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV (NCT01003964) | National Cancer Center, Korea | 2009-02-01 |
| Vibration Response Imaging (VRI) in the Preoperative Management in Patients With Non-Small Cell Lung Cancer (NCT00845143) | Heidelberg University | 2009-02-01 |
| Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment (NCT00840125) | Meir Medical Center | 2009-02-01 |
| Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer (NCT00706862) | Agennix | 2009-02-01 |
| Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer (NCT00901537) | Loma Linda University | 2009-02-01 |
| Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients (NCT01040780) | Betta Pharmaceuticals Co., Ltd. | 2009-02-01 |
| Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC) (NCT00826449) | M.D. Anderson Cancer Center | 2009-02-01 |
| QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors (NCT00819169) | NantCell, Inc. | 2009-01-16 |
| Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung Cancer (NCT04266691) | Zhejiang Cancer Hospital | 2009-01-01 |
| Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3) (NCT00599755) | Merck Sharp & Dohme LLC | 2009-01-01 |
| A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer (NCT00735696) | Eli Lilly and Company | 2009-01-01 |
| Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer (NCT00732303) | Hoosier Cancer Research Network | 2009-01-01 |
| Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC Family (NCT00779389) | University of Pittsburgh | 2009-01-01 |
| Clinical Significance of Circulating Tumour Cells in Resectable Lung Cancer Patients (NCT05619562) | The Institute of Molecular and Translational Medicine, Czech Republic | 2009-01-01 |
| Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer (NCT00850785) | Providence Health & Services | 2009-01-01 |
| A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer (NCT00830245) | Clinical Research Center for Solid Tumor, Korea | 2009-01-01 |
| A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of Lung (NCT00816868) | Sun Yat-sen University | 2009-01-01 |
| Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer (NCT01019798) | Taipei Medical University Hospital | 2009-01-01 |
| A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer (NCT00762034) | Eli Lilly and Company | 2008-12-01 |
| Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy (NCT00960115) | Merck KGaA, Darmstadt, Germany | 2008-12-01 |
| Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC (NCT00828841) | Accelerated Community Oncology Research Network | 2008-12-01 |
| A Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer (NCT00885963) | Cyclacel Pharmaceuticals, Inc. | 2008-12-01 |
| Phase I/II Calcitriol in Lung Cancer (NCT00794547) | University of Michigan Rogel Cancer Center | 2008-12-01 |
| A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer (NCT00738387) | Novartis Pharmaceuticals | 2008-12-01 |
| Video-assisted Thoracoscopic Surgery for Stage IIIA Non-Small Cell Lung Cancer (NCT00862004) | The First Affiliated Hospital of Guangzhou Medical University | 2008-12-01 |
| Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer (NCT00840749) | Accuray Incorporated | 2008-12-01 |
| Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (NCT00922584) | Chinese Society of Lung Cancer | 2008-12-01 |
| Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC) (NCT01687439) | Fudan University | 2008-12-01 |
| A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma (NCT00794417) | Regeneron Pharmaceuticals | 2008-11-30 |
| The Method ISET (Insulation by Size of Epithelial Tumor Cells) (NCT00818558) | Centre Hospitalier Universitaire de Nice | 2008-11-03 |
| A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen (NCT00769067) | Pfizer | 2008-11-01 |
| 0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer (NCT00771953) | University of Maryland, Baltimore | 2008-11-01 |
| Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer (NCT00707304) | Agennix | 2008-11-01 |
| A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung Cancer (NCT00789373) | Eli Lilly and Company | 2008-11-01 |
| Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer (NCT00755170) | Hellenic Oncology Research Group | 2008-11-01 |
| Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer (NCT00753909) | Hellenic Oncology Research Group | 2008-11-01 |
| Hydroxychloroquine and Gefitinib to Treat Lung Cancer (NCT00809237) | National University Hospital, Singapore | 2008-11-01 |
| Randomized Gefitinib Trial (NCT00807066) | Fondazione Humanitas per la Ricerca | 2008-11-01 |
| A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy. (NCT00773383) | Hoffmann-La Roche | 2008-11-01 |
| Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia (NCT00783705) | National Cancer Institute (NCI) | 2008-11-01 |
| Bevacizumab Versus Docetaxel/Erlotinib on Tumor Metrics in Patients With Previously Untreated Advanced Non Small Cell Lung Cancer (NCT04257864) | Hellenic Cooperative Oncology Group | 2008-11-01 |
| A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies (NCT00730639) | Bristol-Myers Squibb | 2008-10-30 |
| Radiation Therapy (XRT) and ZD6474 in Non-Small Cell Lung Cancer (NSCLC) (NCT00745732) | M.D. Anderson Cancer Center | 2008-10-09 |
| Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine (NCT00753714) | Genzyme, a Sanofi Company | 2008-10-01 |
| Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer (NCT00701870) | Telik | 2008-10-01 |
| Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced Rash (NCT00803842) | Northwestern University | 2008-10-01 |
| Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer (NCT00714246) | Milton S. Hershey Medical Center | 2008-10-01 |